This questionnaire takes approximately 8–10 minutes. Your answers are reviewed by a licensed provider before any protocol is recommended.
01 of 12
Let's start with you.
Basic information used to create your clinical record.
Your provider must be licensed in your state⚠ Provider availability in this state requires verification.
1 of 12
02 of 12
Body composition.
Used to calculate clinical dosing thresholds and assess baseline metabolic status.
⚠ Yellow flag — provider review before peptide initiation
2 of 12
03 of 12
Medical history.
Select anything that applies to you, past or present. This directly shapes your protocol.
Select all that apply
Yes
No
3 of 12
04 of 12
What you're currently taking.
Interactions between peptides and certain medications require provider attention. Please be thorough.
Yes
No
Include name, dose, and frequency if known
⚠ Potential interaction with GLP-1 and glucose-regulating peptides
Yes
No
⛔ Red flag — provider review required before GLP-1 initiation
e.g. Warfarin, Eliquis, Xarelto, Plavix, daily aspirin 325mg+
Yes
No
⚠ Yellow flag — relevant for peptide injection site guidance
e.g. Prednisone, Methotrexate, Tacrolimus, biologics
Yes
No
⚠ Yellow flag — may affect immune-modulating peptide protocols
Yes
No
Include dose and frequency if known
Yes
No
Yes
No
⚠ Yellow flag — relevant for compounded peptide vial selection
4 of 12
05 of 12
Reproductive health.
Hormonal status significantly affects peptide protocol design and safety thresholds.
Yes
No
⛔ Red flag — peptide therapy is contraindicated during pregnancy and active conception attempts. Your intake will be paused and a provider will follow up.
Yes
No
⛔ Red flag — provider review required. Most peptide protocols are not recommended during lactation.
e.g. birth control pill, IUD, HRT, testosterone, DHEA
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
⚠ Yellow flag — some peptides interact with the HPG axis
5 of 12
06 of 12
Surgical history.
Prior surgeries, especially GI-related, affect peptide tolerability and dosing.
Yes
No
e.g. gastric sleeve, gastric bypass, lap band
Yes
No
⚠ Yellow flag — GLP-1 protocols require modified initiation approach
Yes
No
⚠ Yellow flag — history reviewed by provider before growth-factor peptides
6 of 12
07 of 12
Family health history.
Genetic predispositions can influence which protocols are appropriate for long-term use.
Select all that apply
7 of 12
08 of 12
Digestive and mental health.
GI tolerance and mental health baseline are both relevant to protocol selection and support planning.
Select all that apply
This helps us select protocols least likely to affect mood and sleep architecture
Yes
No
Yes
No
Yes
No
8 of 12
09 of 12
How you live.
Lifestyle context helps us personalize your protocol and set realistic expectations.
This information is strictly clinical and confidential. It directly informs dosing decisions.
9 of 12
10 of 12
Prior experience.
Your history with peptides and GLP-1s shapes where we start and what to watch for.
e.g. Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), Liraglutide
Yes
No
e.g. BPC-157, TB-500, Ipamorelin, CJC-1295, PT-141, Epithalon, MOTS-C
Yes
No
Yes
No
⚠ Yellow flag — prior adverse peptide reactions reviewed by provider
Yes
No
⚠ Yellow flag — concurrent protocols require provider coordination
10 of 12
11 of 12
What you're here for.
Your goals guide protocol selection. Be specific — our providers read every word.
Select up to three
This becomes your primary treatment objective
11 of 12
12 of 12
Review and consent.
Please read the statements below carefully. Your signature confirms accuracy and authorizes clinical review.
Accuracy Statement
I confirm that the information I have provided in this intake is accurate and complete to the best of my knowledge. I understand that withholding or misrepresenting medical history may affect the safety of any recommended protocol and may constitute grounds for discontinuation of care.
Telehealth Consent
I consent to receive telehealth services from Project Preservation's licensed providers. I understand that telehealth involves the delivery of healthcare services using electronic communications and that my provider will not physically examine me. I understand I may discontinue my participation at any time.
Treatment Authorization
I authorize Project Preservation's licensed providers to review my intake, order laboratory work if deemed necessary, and design a peptide protocol appropriate for my history and goals. I understand that no prescription will be issued without provider approval, and that certain responses may require additional follow-up before a protocol can be initiated.
Compounded Medication Acknowledgment
I understand that peptides prescribed through Project Preservation are compounded medications prepared by a licensed 503A or 503B pharmacy. Compounded medications are not FDA-approved but are prepared under applicable pharmacy regulations. I have been given the opportunity to ask questions about my protocol before it begins.
Privacy Notice
My health information is protected under applicable federal and state privacy laws, including HIPAA. I understand my rights regarding the use and disclosure of my protected health information, including the right to access my records and request corrections.
Type your full name as it appears on your intake to confirm agreement
Internal — Clinical Triage Summary
12 of 12
✦
You're in the system.
Your intake has been received. A licensed provider will review your information within 24–48 hours. You'll hear from us via text with your next steps.